Dr Reddys Laboratories (RDY) Receivables - Other (2017 - 2026)

Dr Reddys Laboratories' Receivables - Other history runs 10 years deep, the most recent figure standing at $87513.3 for Q1 2026.

• In Q1 2026, Receivables - Other fell 5.27% year-over-year to $87513.3; the TTM figure through Mar 2026 stood at $87513.3 (down 5.27% YoY), while the FY2026 annual figure was $90638.6, down 4.24% from the prior year.
• Receivables - Other was $87513.3 for Q1 2026 at Dr Reddys Laboratories, down from $92384.3 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $590035.9 in Q1 2024 to a low of $87513.3 in Q1 2026.
• Historically, Receivables - Other has averaged $279843.0 across 5 years, with a median of $97318.8 in 2023.
• The sharpest annual moves came in 2024 and 2025: Receivables - Other jumped 506.29% in 2024, then tumbled 84.34% in 2025.
• A 5-year view of Receivables - Other shows it stood at $531962.9 in 2022, then plunged by 81.71% to $97318.8 in 2023, then surged by 506.29% to $590035.9 in 2024, then sank by 84.34% to $92384.3 in 2025, then retreated by 5.27% to $87513.3 in 2026.
• The last three Receivables - Other figures came in at $87513.3 (Q1 2026), $92384.3 (Q1 2025), and $590035.9 (Q1 2024), per Business Quant data.